Clinical trials
Withdrawn Phase 2 Idiopathic Pulmonary Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Actelion | 1 |
| AmMax Bio, Inc. | 1 |
| Biosplice Therapeutics, Inc. | 1 |
| Blade Therapeutics | 1 |
| Hoffmann-La Roche | 1 |
| Modern Biosciences Ltd | 1 |
| University of Kansas Medical Center | 1 |
| University of Pittsburgh | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Idiopathic Pulmonary Fibrosis | 8 |
| Alveolitis, Extrinsic Allergic | 1 |
| Pulmonary Fibrosis | 1 |
| Respiratory Aspiration | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.